Hill (Ret) James T. General's Net Worth
$0
Who is Hill (Ret) James T. General?
Hill (Ret) James T. General does not have any significant net worth to report based on the numbers we have. This is based on reported shares in iBioPharma, Inc..
SEC CIK
Hill (Ret) James T. General's CIK is 0001441718
Past Insider Trading and Trends
2019 was Hill (Ret) James T. General's most active year for acquiring shares with 9 total transactions. Hill (Ret) James T. General's most active month to acquire stocks was the month of January. 2019 was Hill (Ret) James T. General's most active year for disposing of shares, totalling 8 transactions. Hill (Ret) James T. General's most active month to dispose stocks was the month of January. 2015 saw Hill (Ret) James T. General paying a total of $172,000.00 for 100,000 shares, this is the most they've acquired in one year. In 2019 Hill (Ret) James T. General cashed out on 49,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
iBioPharma, Inc. (IBIO) Snapshot price: $1.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5 - Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |